DNAPrint Genomics, Inc. Stock OTC Bulletin Board
Equities
DNAG
US23324Q2021
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Financials (USD)
Sales 2005 | 1.28M | Sales 2006 | 2.43M | Capitalization | 3.79M |
---|---|---|---|---|---|
Net income 2005 | -8M | Net income 2006 | -12M | EV / Sales 2005 | 1.89 x |
Net cash position 2005 | 737K | Net cash position 2006 | 1.21M | EV / Sales 2006 | 1.06 x |
P/E ratio 2005 |
-0.23
x | P/E ratio 2006 |
-0.27
x | Employees | - |
Yield 2005 * |
-
| Yield 2006 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Monica Tamborini
DFI | Director of Finance/CFO | - | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DNAG Stock
- DNAG Stock